For those of you who are clinically minded--
Gemzar in an IV drip, every-other week. It takes about 1 1/2 hours to get this done.
Xeloda, an oral med, seven days, then seven days off.
Gemzar is the "gold standard" for pancreatic cases, has few and mild side effects, and a record of "good survivability." I figure any survivability is good. Xeloda has more side effects, but all are manageable.
Right now, there is a serious conversation going on between Blue Cross/Blue Shield (our Part D coverage) and my Oncologist about Xeloda. I will be surprised if the Blues approve it. But between the $375 a year deductible, the 25% co-pay, and the "donut hole," it would not be too upsetting to hear.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment